Susquehanna International Group, LLP Chroma Dex Corp. Call Options Transaction History

Susquehanna International Group, LLP

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$2.51 - $3.8 $115,459 - $174,800	-46,000 Reduced 62.33%	27,800 $101,000
Q2 2024 Aug 15, 2024	BUY	$2.44 - $4.32 $6,100 - $10,800	2,500 Added 3.51%	73,800 $201,000
Q1 2024 May 07, 2024	BUY	$1.36 - $3.84 $96,968 - $273,792	71,300 New	71,300 $248,000
Q4 2021 Feb 14, 2022	SELL	$3.74 - $6.7 $618,970 - $1.11 Million	-165,500 Reduced 90.78%	16,800 $63,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.41 $157,300 - $270,660	26,000 Added 16.63%	182,300 $1.14 Million
Q2 2021 Aug 11, 2021	SELL	$6.66 - $10.92 $577,422 - $946,764	-86,700 Reduced 35.68%	156,300 $1.54 Million
Q1 2021 May 17, 2021	BUY	$4.59 - $18.74 $990,063 - $4.04 Million	215,700 Added 790.11%	243,000 $2.27 Million
Q1 2020 May 15, 2020	BUY	$2.54 - $4.75 $26,670 - $49,875	10,500 Added 62.5%	27,300 $89,000
Q4 2019 Feb 14, 2020	BUY	$2.83 - $4.61 $10,188 - $16,596	3,600 Added 27.27%	16,800 $72,000
Q3 2019 Nov 14, 2019	SELL	$3.83 - $4.72 $37,151 - $45,784	-9,700 Reduced 42.36%	13,200 $52,000
Q2 2019 Aug 14, 2019	BUY	$3.71 - $4.83 $13,356 - $17,388	3,600 Added 18.65%	22,900 $106,000
Q1 2019 May 15, 2019	BUY	$3.2 - $4.19 $61,760 - $80,867	19,300 New	19,300 $81,000
Q3 2018 Nov 14, 2018	SELL	$3.5 - $4.91 $191,450 - $268,577	-54,700 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$3.22 - $4.43 $102,718 - $141,317	-31,900 Reduced 36.84%	54,700 $203,000
Q1 2018 May 15, 2018	BUY	$4.05 - $6.46 $350,730 - $559,436	86,600 New	86,600 $364,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $466M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.